SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a single arm screening study. All eligible participants will be subjected to low dose CT (LDCT) screening and biomarker testing. The primary aim of the study is to determine the feasibility of conducting LDCT screening in at-risk populations for lung cancer in Singapore: * For the smoker population, LDCT screening for lung cancer will be implemented in accordance to Academy of Medicine, Singapore screening test guidelines with the aim of investigating the feasibility of instituting lung cancer screening clinical service in Singapore. * For the non-smoker population, LDCT screening for lung cancer will be introduced to systematically collect baseline data to better understand and provide evidence for lung adenocarcinoma in never-smoker phenotype that is unique to East Asia/Singapore. This will help address unmet needs in local population research as reported by Academy of Medicine, Singapore, to validate risk factors and inform future screening guidelines for the at-risk population. Screening results will be reported based on Lung CT Screening Reporting \& Data System (Lung-RADS).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
Healthy Volunteers: t
View:

⁃ Smoker:

• Participant is willing and able to give informed consent for participation in the study

• Male or female, aged 50-80 years of age

• No prior history of cancer, or cancer free in the last 5 years and not currently on cancer treatment

• ECOG 0/1

• Current or former smokers with at least 30 pack years of smoking history

• Willing to comply with study follow-up schedule and tests

• Willing to cover the costs of downstream standard of care management and investigations including doctor's fee, CT scan and biopsy etc.

• A Singapore citizen/Permanent Resident of Singapore

⁃ Non-Smoker:

• Participant is willing and able to give informed consent for participation in the study

• Male, or female, aged 50-80 years of age

• No prior history of cancer, or cancer free in the last 5 years and not currently on cancer treatment

• ECOG 0/1

• Never smoker, or has smoked less than 10 pack-years and has quit smoking for at least 15 years

• Family history of lung cancer up to 2nd degree relatives

• Willing to comply with study follow-up schedule and tests

• Willing to cover the costs of downstream standard of care management and investigations including doctor's fee, CT scan and biopsy etc.

• A Singapore citizen/Permanent Resident of Singapore

Locations
Other Locations
Singapore
National Cancer Centre, Singapore
RECRUITING
Singapore
National Heart Centre Singapore
RECRUITING
Singapore
Singapore General Hospital
RECRUITING
Singapore
Contact Information
Primary
Darren Wan-Teck Lim, MD
darren.lim.w.t@singhealth.com.sg
64368000
Backup
Gillianne Geet-Yi Lai, MD
gillianne.lai.g.y@singhealth.com.sg
64368000
Time Frame
Start Date: 2022-07-21
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 1000
Treatments
Experimental: Low-dose CT of the Chest (LDCT) + Blood sampling
Related Therapeutic Areas
Sponsors
Collaborators: Sengkang General Hospital, Singapore General Hospital, Duke-NUS Graduate Medical School, Genome Institute of Singapore, National University of Singapore, Changi General Hospital, National Heart Centre Singapore
Leads: National Cancer Centre, Singapore

This content was sourced from clinicaltrials.gov